Literature DB >> 8605683

Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation.

K Rasmussen1, J Møller, M Lyngbak, A M Pedersen, L Dybkjaer.   

Abstract

We present reference intervals for total homocysteine and methylmalonic acid in plasma based on samples from 126 women (ages 20-85 years, median 49 years) and 109 men (ages 20-84 years, median 50 years). The central 0.95 interval for methylmalonic acid was 0.08-0.28 micromol/L. Supplementation with cyanocobalamin caused a nonsignificant decrease in methylmalonic acid. Supplementation with folic acid caused a decrease in homocysteine concentrations, with data analysis identifying two significantly different clusters: 182 subjects with the lowest initial concentrations (7.76 +/- 1.54 micromol/L, mean +/- SD) and the smallest decrease (1.26 +/- 0.96 micromol/L), and 53 subjects with the highest initial concentrations (12.33 +/- 2.04 micromol/L) and greatest decrease (4.14 +/- 1.32 micromol/L). We argue in favor of the age- and gender-specific central 0.95 intervals obtained for the 182 subjects before being supplemented with folic acid: 4.6-8.1 micromol/L for subjects at <30 years; 4.5-7.9 micromol/L for women, ages 30-59 years; 6.3-11.2 micromol/L for men, ages 30-59 years; and 5.8-11.9 micromol/L for subjects at >60 years.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605683

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  32 in total

1.  Hyperhomocyst(e)inemia.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-02

Review 2.  Cobalamin status in children.

Authors:  Anne-Lise Bjørke-Monsen; Per Magne Ueland
Journal:  J Inherit Metab Dis       Date:  2010-05-27       Impact factor: 4.982

3.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

4.  Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study.

Authors:  A B Guttormsen; P M Ueland; I Nesthus; O Nygård; J Schneede; S E Vollset; H Refsum
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 5.  ACP Broadsheet No 152: March 1998. Clinical implications of plasma homocysteine measurement in cardiovascular disease.

Authors:  R A Still; I F McDowell
Journal:  J Clin Pathol       Date:  1998-03       Impact factor: 3.411

Review 6.  Assessment of homocysteine status.

Authors:  H Refsum; T Fiskerstrand; A B Guttormsen; P M Ueland
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

7.  An LC-MS/MS method for serum methylmalonic acid suitable for monitoring vitamin B12 status in population surveys.

Authors:  Ekaterina M Mineva; Mindy Zhang; Daniel J Rabinowitz; Karen W Phinney; Christine M Pfeiffer
Journal:  Anal Bioanal Chem       Date:  2014-09-26       Impact factor: 4.142

8.  Homocysteine levels in aqueous humor and plasma of patients with primary open-angle glaucoma.

Authors:  J B Roedl; S Bleich; U Reulbach; N von Ahsen; U Schlötzer-Schrehardt; R Rejdak; G O H Naumann; F E Kruse; J Kornhuber; A G M Jünemann
Journal:  J Neural Transm (Vienna)       Date:  2006-08-24       Impact factor: 3.575

9.  Age-specific reference ranges are needed to interpret serum methylmalonic acid concentrations in the US population.

Authors:  Ekaterina M Mineva; Maya R Sternberg; Mindy Zhang; Yutaka Aoki; Renee Storandt; Regan L Bailey; Christine M Pfeiffer
Journal:  Am J Clin Nutr       Date:  2019-07-01       Impact factor: 7.045

Review 10.  Age-related changes in cobalamin (vitamin B12) handling. Implications for therapy.

Authors:  H Nilsson-Ehle
Journal:  Drugs Aging       Date:  1998-04       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.